Published in AIDS on January 01, 1995
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clin Infect Dis (2009) 1.86
AIDS survival and progression in black Africans living in south London, 1986-1994. Genitourin Med (1996) 1.60
The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One (2010) 1.34
Survival by AIDS defining condition in rural Uganda. Sex Transm Infect (2000) 1.02
Clinical dilemmas in palliative care for HIV infection. J R Soc Med (2001) 0.82
Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death. J Acquir Immune Defic Syndr (2016) 0.75
Caring for patients with HIV and AIDS in middle income countries. BMJ (1996) 0.75
Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study. AIDS Res Ther (2011) 0.75
HIV-related non-Hodgkin's lymphoma in Calgary. Can J Infect Dis (1996) 0.75
Prognostic factors correlated with survival in AIDS patients. Eur J Epidemiol (1999) 0.75
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS (1998) 8.88
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet (1999) 7.08
Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62
Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Health Technol Assess (2007) 6.55
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat (2006) 5.10
Adverse effects of antiretroviral therapy. Lancet (2000) 4.84
Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet (1985) 4.83
Interleukin-2 therapy in patients with HIV infection. N Engl J Med (2009) 4.38
The 2010 Royal Australasian College of Physicians' policy statement 'Circumcision of infant males' is not evidence based. Intern Med J (2012) 4.15
A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med (1995) 3.89
Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med (2001) 3.55
Insertional mutagenesis of genes required for seed development in Arabidopsis thaliana. Genetics (2001) 3.49
Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol (1996) 3.48
Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet (1985) 3.33
Use of personal medical records for research purposes. BMJ (1994) 3.29
Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS (1999) 3.28
Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet (1998) 3.22
Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet (1997) 2.97
Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology (2001) 2.90
Primary HIV infection: host responses and intervention strategies. AIDS (1991) 2.80
Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol (2008) 2.74
A primary genetic linkage map for human chromosome 12. Genomics (1987) 2.72
How effective is nicotine replacement therapy in helping people to stop smoking? BMJ (1994) 2.68
Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med (1992) 2.65
Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ (1998) 2.64
Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet (1992) 2.60
The prediction of criminal and violent recidivism among mentally disordered offenders: a meta-analysis. Psychol Bull (1998) 2.60
Prostaglandins and breast cancer. Lancet (1977) 2.54
Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis (1996) 2.44
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet (1998) 2.43
An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet (2003) 2.43
CD8+ lymphocyte responses to antiretroviral therapy of HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 2.23
Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytes. Science (1983) 2.21
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS (2001) 2.17
HIV disease progression in Australia in the time of combination antiretroviral therapies. Med J Aust (1998) 2.16
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia. Nat Med (2001) 2.14
An appraisal of the efficacy and cost effectiveness of antenatal screening for hepatitis B. J Med Screen (1997) 2.12
Vaccinia virus utilizes microtubules for movement to the cell surface. J Cell Biol (2001) 2.10
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals. AIDS (2001) 2.03
Trends in infectious disease mortality in Australia, 1979-1994. Med J Aust (1998) 2.02
Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men. Med J Aust (1989) 2.02
Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ (1997) 1.92
Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs. Med J Aust (2000) 1.92
Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease. J Infect Dis (2000) 1.91
The acquired immunodeficiency syndrome in Australia: incidence 1982-1991. Med J Aust (1993) 1.89
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88
CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS (1991) 1.85
The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Med J Aust (1999) 1.85
Acquired immunodeficiency without evidence of HIV infection: national retrospective survey. BMJ (1994) 1.78
3D time-resolved MR angiography (MRA) of the carotid arteries with time-resolved imaging with stochastic trajectories: comparison with 3D contrast-enhanced Bolus-Chase MRA and 3D time-of-flight MRA. AJNR Am J Neuroradiol (2008) 1.74
Ribavirin: a role in HIV infection? J Acquir Immune Defic Syndr (1990) 1.74
Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer (1988) 1.74
Semiconductor quantum dots and quantum dot arrays and applications of multiple exciton generation to third-generation photovoltaic solar cells. Chem Rev (2010) 1.72
Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS (2001) 1.72
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. J Infect Dis (1999) 1.70
The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J Infect Dis (1991) 1.69
Screening, ethics, and the law. BMJ (1992) 1.67
Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol (1994) 1.67
Breast cancer, prostaglandins, and bone metastases. Lancet (1975) 1.64
Prognostic factors in hormone-resistant progressing cancer of the prostate. Ann Oncol (1992) 1.61
Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol (2001) 1.61
Measuring children's participation in recreation and leisure activities: construct validation of the CAPE and PAC. Child Care Health Dev (2007) 1.61
Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the Health in Men Study. Sex Transm Infect (2006) 1.59
Perinatal exposure to HIV in Australia, 1982-1994. Med J Aust (1997) 1.54
Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood (1993) 1.54
Survival analyses of randomized clinical trials adjusted for patients who switch treatments. Stat Med (1996) 1.54
Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994. Am J Epidemiol (1997) 1.52
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia (2008) 1.51
Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med J Aust (2000) 1.50
Iridoschisis and keratoconus. Cornea (1994) 1.50
Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother Oncol (1997) 1.47
Risk of cancer in people with AIDS. AIDS (1999) 1.47
Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room. AIDS (1996) 1.46
Arabidopsis genes essential for seedling viability: isolation of insertional mutants and molecular cloning. Genetics (2001) 1.46
Oral contraceptives and breast cancer: a national study. Br Med J (Clin Res Ed) (1986) 1.44
The neurological features of early and 'latent' human immunodeficiency virus infection. Aust N Z J Med (1989) 1.42
Syringe HIV seroprevalence and behavioural and demographic characteristics of intravenous drug users in Sydney, Australia, 1987. AIDS (1988) 1.41
Detection of HCV RNA in semen. Lancet (2000) 1.41
Magnetic repulsion of linear accelerator contaminates. Med Phys (1996) 1.41
Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group. J Infect Dis (1998) 1.41
Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer (2011) 1.41
Use of interventions for reducing mother-to-child transmission of HIV in Australia. Med J Aust (2001) 1.40
Bile acid malabsorption in HIV infected patients with chronic diarrhoea. Aust N Z J Med (1996) 1.40